AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy
In the context of future adeno-associated viral (AAV)-based clinical trials for Duchenne myopathy, AAV genome fate in dystrophic muscles is of importance considering the viral capsid immunogenicity that prohibits recurring treatments. We showed that AAV genomes encoding non-therapeutic U7 were lost...
मुख्य लेखकों: | Le Hir, M, Goyenvalle, A, Peccate, C, Précigout, G, Davies, K, Voit, T, Garcia, L, Lorain, S |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2013
|
समान संसाधन
-
AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
द्वारा: Goyenvalle, A, और अन्य
प्रकाशित: (2010) -
AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
द्वारा: Goyenvalle, A, और अन्य
प्रकाशित: (2011) -
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
द्वारा: Goyenvalle, A, और अन्य
प्रकाशित: (2012) -
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
द्वारा: Goyenvalle, A, और अन्य
प्रकाशित: (2012) -
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
द्वारा: Philippine Aupy, और अन्य
प्रकाशित: (2020-06-01)